Y. Wang

First name
Y.
Last name
Wang
Afonso, A., Schmiedl, S., Becker, C., Tcherny-Lessenot, S., Primatesta, P., Plana, E., et al. (2016). A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-016-2071-8
Wang, Y., Pfeiffer, R. M., Alsaggaf, R., Meeraus, W., Gage, J. C., Anderson, L. A., et al. (2018). Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. Int J Cancer. http://doi.org/10.1002/ijc.31143
Alsaggaf, R., St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Wagner, K. R., et al. (2018). Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity. JNCI Cancer Spectr. http://doi.org/10.1093/jncics/pky052
Alsaggaf, R., Pfeiffer, R. M., Wang, Y., St George, D. M. M., Zhan, M., Wagner, K. R., et al. (2019). Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I. Int J Cancer. http://doi.org/10.1002/ijc.32801
Alsaggaf, R., St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Anderson, L. A., et al. (2019). Benign tumors in myotonic dystrophy type I target disease-related cancer sites. Ann Clin Transl Neurol. http://doi.org/10.1002/acn3.50856
Sarmanova, A., Doherty, M., Kuo, C., Wei, J., Abhishek, A., Mallen, C., et al. (2020). Statin use and risk of joint replacement due to osteoarthritis and rheumatoid arthritis: a propensity-score matched longitudinal cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keaa044
Varma, V. R., Wang, Y., An, Y., Varma, S., Bilgel, M., Doshi, J., et al. (2021). Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study. PLoS Med. http://doi.org/10.1371/journal.pmed.1003615